Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 14.12
(-1.05%)
CNY 14.12
(-1.05%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 307.46 Million CNY | -78.56% |
| 2022 | 1.43 Billion CNY | 23.33% |
| 2021 | 1.16 Billion CNY | 44.83% |
| 2020 | 802.93 Million CNY | 39.5% |
| 2019 | 575.56 Million CNY | 48.11% |
| 2018 | 388.6 Million CNY | 11.16% |
| 2017 | 349.59 Million CNY | 33.05% |
| 2016 | 262.76 Million CNY | 50.33% |
| 2015 | 174.79 Million CNY | 40.3% |
| 2014 | 124.58 Million CNY | 44.71% |
| 2013 | 86.09 Million CNY | 43.04% |
| 2012 | 60.18 Million CNY | 42.6% |
| 2011 | 42.2 Million CNY | 30.23% |
| 2010 | 32.41 Million CNY | 88.78% |
| 2009 | 17.16 Million CNY | 160.54% |
| 2008 | 6.58 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 48.57 Million CNY | 109.65% |
| 2024 Q1 | 23.17 Million CNY | 110.37% |
| 2024 Q3 | 59.11 Million CNY | 21.68% |
| 2023 FY | 307.46 Million CNY | -78.56% |
| 2023 Q3 | 77.58 Million CNY | -73.52% |
| 2023 Q2 | 293.01 Million CNY | 14.98% |
| 2023 Q4 | -223.41 Million CNY | -387.96% |
| 2023 Q1 | 254.85 Million CNY | 125.35% |
| 2022 Q3 | 547.96 Million CNY | -51.34% |
| 2022 Q1 | 753.71 Million CNY | 1179.07% |
| 2022 FY | 1.43 Billion CNY | 23.33% |
| 2022 Q4 | -1 Billion CNY | -283.47% |
| 2022 Q2 | 1.12 Billion CNY | 49.41% |
| 2021 FY | 1.16 Billion CNY | 44.83% |
| 2021 Q1 | 338.55 Million CNY | 451.12% |
| 2021 Q4 | -69.84 Million CNY | -113.81% |
| 2021 Q3 | 505.64 Million CNY | 30.14% |
| 2021 Q2 | 388.52 Million CNY | 14.76% |
| 2020 Q2 | 494.7 Million CNY | 7337.38% |
| 2020 Q4 | -96.42 Million CNY | -124.23% |
| 2020 FY | 802.93 Million CNY | 39.5% |
| 2020 Q3 | 397.99 Million CNY | -19.55% |
| 2020 Q1 | 6.65 Million CNY | 249.25% |
| 2019 Q4 | -4.45 Million CNY | -104.29% |
| 2019 FY | 575.56 Million CNY | 48.11% |
| 2019 Q1 | 72.57 Million CNY | -24.89% |
| 2019 Q2 | 175.38 Million CNY | 141.66% |
| 2019 Q3 | 103.77 Million CNY | -40.83% |
| 2018 Q2 | 141.26 Million CNY | 124.92% |
| 2018 Q1 | 62.8 Million CNY | -37.0% |
| 2018 Q3 | 87.91 Million CNY | -37.77% |
| 2018 Q4 | 96.62 Million CNY | 9.91% |
| 2018 FY | 388.6 Million CNY | 11.16% |
| 2017 Q1 | 55.99 Million CNY | -24.97% |
| 2017 Q3 | 68.81 Million CNY | -44.98% |
| 2017 Q4 | 99.69 Million CNY | 44.88% |
| 2017 FY | 349.59 Million CNY | 33.05% |
| 2017 Q2 | 125.08 Million CNY | 123.38% |
| 2016 FY | 262.76 Million CNY | 50.33% |
| 2016 Q4 | 74.62 Million CNY | 41.91% |
| 2016 Q3 | 52.58 Million CNY | -45.15% |
| 2016 Q2 | 95.87 Million CNY | 141.65% |
| 2016 Q1 | 39.67 Million CNY | -20.39% |
| 2015 Q3 | 36.01 Million CNY | -42.17% |
| 2015 Q4 | 49.83 Million CNY | 38.39% |
| 2015 Q1 | 26.67 Million CNY | -25.28% |
| 2015 FY | 174.79 Million CNY | 40.3% |
| 2015 Q2 | 62.27 Million CNY | 133.43% |
| 2014 Q3 | 26.29 Million CNY | -39.75% |
| 2014 FY | 124.58 Million CNY | 44.71% |
| 2014 Q1 | 18.94 Million CNY | -22.07% |
| 2014 Q2 | 43.64 Million CNY | 130.38% |
| 2014 Q4 | 35.7 Million CNY | 35.78% |
| 2013 Q4 | 24.3 Million CNY | 47.86% |
| 2013 FY | 86.09 Million CNY | 43.04% |
| 2013 Q1 | 15.35 Million CNY | -16.71% |
| 2013 Q2 | 29.98 Million CNY | 95.28% |
| 2013 Q3 | 16.44 Million CNY | -45.18% |
| 2012 Q2 | 18.58 Million CNY | 53.48% |
| 2012 Q4 | 18.43 Million CNY | 66.84% |
| 2012 Q3 | 11.05 Million CNY | -40.55% |
| 2012 Q1 | 12.11 Million CNY | 2.91% |
| 2012 FY | 60.18 Million CNY | 42.6% |
| 2011 Q4 | 11.76 Million CNY | 50.55% |
| 2011 FY | 42.2 Million CNY | 30.23% |
| 2011 Q2 | 13.19 Million CNY | 39.95% |
| 2011 Q1 | 9.42 Million CNY | -6.64% |
| 2011 Q3 | 7.81 Million CNY | -40.75% |
| 2010 Q1 | 6.98 Million CNY | 0.0% |
| 2010 Q4 | 10.09 Million CNY | 78.53% |
| 2010 Q3 | 5.65 Million CNY | -41.54% |
| 2010 Q2 | 9.67 Million CNY | 38.59% |
| 2010 FY | 32.41 Million CNY | 88.78% |
| 2009 FY | 17.16 Million CNY | 160.54% |
| 2008 FY | 6.58 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion CNY | 84.816% |
| Dirui Industrial Co.,Ltd. | 275.58 Million CNY | -11.565% |
| Beijing Strong Biotechnologies, Inc. | 523.74 Million CNY | 41.295% |
| Medicalsystem Biotechnology Co., Ltd. | 256.55 Million CNY | -19.844% |
| Maccura Biotechnology Co.Ltd | 312.61 Million CNY | 1.65% |
| Guangzhou Wondfo Biotech Co.,Ltd | 487.62 Million CNY | 36.947% |
| Guangdong Hybribio Biotech Co.,Ltd. | 140.47 Million CNY | -118.877% |
| BGI Genomics Co., Ltd. | 92.9 Million CNY | -230.958% |
| Amoy Diagnostics Co., Ltd. | 261.48 Million CNY | -17.583% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | -141.59 Million CNY | 317.147% |